S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Dare Bioscience News Headlines (NASDAQ:DARE)

$0.77
-0.02 (-2.53 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$0.77
Now: $0.77
$0.80
50-Day Range
$0.72
MA: $0.79
$0.87
52-Week Range
$0.60
Now: $0.77
$3.25
Volume8,900 shs
Average Volume497,455 shs
Market Capitalization$12.85 million
P/E RatioN/A
Dividend YieldN/A
Beta1.91

Headlines

Dare Bioscience (NASDAQ DARE) News Headlines

Source:
DateHeadline
Short Interest in Dare Bioscience Inc (NASDAQ:DARE) Declines By 12.6%Short Interest in Dare Bioscience Inc (NASDAQ:DARE) Declines By 12.6%
www.americanbankingnews.com - October 16 at 6:32 PM
Daré Bioscience to Participate in Two Upcoming Investor ConferencesDaré Bioscience to Participate in Two Upcoming Investor Conferences
finance.yahoo.com - October 14 at 8:34 AM
Daré Bioscience Announces a Poster Presentation on a Pharmacokinetic Study of DARE-FRT1, in Development for Sustained-Release Progesterone Therapy for Pregnancy Maintenance, at the American Society for Reproductive Medicine 2019 Scientific Congress & ExpoDaré Bioscience Announces a Poster Presentation on a Pharmacokinetic Study of DARE-FRT1, in Development for Sustained-Release Progesterone Therapy for Pregnancy Maintenance, at the American Society for Reproductive Medicine 2019 Scientific Congress & Expo
finance.yahoo.com - October 10 at 8:05 AM
 Analysts Anticipate Dare Bioscience Inc (NASDAQ:DARE) Will Post Earnings of -$0.18 Per Share Analysts Anticipate Dare Bioscience Inc (NASDAQ:DARE) Will Post Earnings of -$0.18 Per Share
www.americanbankingnews.com - October 9 at 5:38 PM
Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-VVA1, a Novel Application of Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy, in the International Journal of PharmaceuticsDaré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-VVA1, a Novel Application of Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy, in the International Journal of Pharmaceutics
finance.yahoo.com - September 11 at 9:55 AM
Daré Bioscience Announces Completion of its Content Validity Study to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal DisorderDaré Bioscience Announces Completion of its Content Validity Study to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
finance.yahoo.com - September 10 at 1:25 PM
Could The Daré Bioscience, Inc. (NASDAQ:DARE) Ownership Structure Tell Us Something Useful?Could The Daré Bioscience, Inc. (NASDAQ:DARE) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - September 10 at 1:25 PM
Daré Bioscience to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceDaré Bioscience to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 4 at 11:28 AM
Dare Bioscience EPS misses by $0.09Dare Bioscience EPS misses by $0.09
seekingalpha.com - August 26 at 6:36 PM
Edited Transcript of DARE earnings conference call or presentation 14-Aug-19 8:30pm GMTEdited Transcript of DARE earnings conference call or presentation 14-Aug-19 8:30pm GMT
finance.yahoo.com - August 15 at 7:57 AM
Daré Bioscience Reports Second Quarter 2019 Financial Results and Company UpdateDaré Bioscience Reports Second Quarter 2019 Financial Results and Company Update
finance.yahoo.com - August 14 at 6:42 PM
Daré Bio up 8% premarket on QIDP tag for DARE-BV1Daré Bio up 8% premarket on QIDP tag for DARE-BV1
seekingalpha.com - August 12 at 11:32 PM
Daré Bioscience Receives QIDP Designation from the FDA for DARE-BV1 for the Treatment of Bacterial VaginosisDaré Bioscience Receives QIDP Designation from the FDA for DARE-BV1 for the Treatment of Bacterial Vaginosis
finance.yahoo.com - August 12 at 11:32 PM
Daré Bioscience Rallies On FDA Designation For Bacterial Vaginosis DrugDaré Bioscience Rallies On FDA Designation For Bacterial Vaginosis Drug
finance.yahoo.com - August 12 at 11:32 PM
BRIEF-Daré Announces Presentation Of Positive Clinical Findings For Vaginal Administration Of Novel Formulation Of Clindamycin PhosphateBRIEF-Daré Announces Presentation Of Positive Clinical Findings For Vaginal Administration Of Novel Formulation Of Clindamycin Phosphate
www.msn.com - August 9 at 12:13 AM
Daré Announces Presentation of Positive Clinical Findings for Vaginal Administration of Novel Formulation of Clindamycin Phosphate for the Treatment of Bacterial Vaginosis at the 2019 Annual Meeting of the Infectious Diseases Society for Obstetrics and GynecologyDaré Announces Presentation of Positive Clinical Findings for Vaginal Administration of Novel Formulation of Clindamycin Phosphate for the Treatment of Bacterial Vaginosis at the 2019 Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology
finance.yahoo.com - August 8 at 9:43 AM
Daré Bioscience to Host Second Quarter 2019 Financial Results and Company Update Conference Call and WebcastDaré Bioscience to Host Second Quarter 2019 Financial Results and Company Update Conference Call and Webcast
finance.yahoo.com - August 6 at 8:33 AM
Daré Announces Presentation of Two Posters at the 2019 Controlled Release Society Annual Meeting & ExpositionDaré Announces Presentation of Two Posters at the 2019 Controlled Release Society Annual Meeting & Exposition
finance.yahoo.com - July 22 at 9:39 AM
Daré Bioscience Announces 2019 AAPS Best Abstract Award for Vaginal Tamoxifen for Treatment of Vulvovaginal Atrophy: Pharmacokinetics and Safety in a Rabbit ModelDaré Bioscience Announces 2019 AAPS Best Abstract Award for Vaginal Tamoxifen for Treatment of Vulvovaginal Atrophy: Pharmacokinetics and Safety in a Rabbit Model
finance.yahoo.com - July 17 at 9:33 AM
Dare Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of DirectorsDare Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of Directors
www.marketwatch.com - July 15 at 9:23 AM
Daré Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of DirectorsDaré Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of Directors
finance.yahoo.com - July 15 at 9:23 AM
The Daré Bioscience (NASDAQ:DARE) Share Price Is Down 35% So Some Shareholders Are Getting WorriedThe Daré Bioscience (NASDAQ:DARE) Share Price Is Down 35% So Some Shareholders Are Getting Worried
finance.yahoo.com - July 11 at 5:27 PM
Daré Bioscience completes enrollment in pre-pivotal Ovaprene studyDaré Bioscience completes enrollment in pre-pivotal Ovaprene study
seekingalpha.com - June 26 at 5:39 PM
Daré Bioscience, Inc. Announces Positive Results in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal DisorderDaré Bioscience, Inc. Announces Positive Results in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
finance.yahoo.com - June 17 at 10:08 AM
Biocom Appoints Additional Members to Board of DirectorsBiocom Appoints Additional Members to Board of Directors
www.businesswire.com - May 29 at 6:09 PM
Daré Bioscience to Present at the 2019 BIO International ConventionDaré Bioscience to Present at the 2019 BIO International Convention
finance.yahoo.com - May 29 at 9:21 AM
DARE: Several Important Milestones, Including Ovaprene PCT Read-Out, Anticipated Later This YearDARE: Several Important Milestones, Including Ovaprene PCT Read-Out, Anticipated Later This Year
finance.yahoo.com - May 28 at 5:29 PM
Edited Transcript of DARE earnings conference call or presentation 14-May-19 8:30pm GMTEdited Transcript of DARE earnings conference call or presentation 14-May-19 8:30pm GMT
finance.yahoo.com - May 15 at 9:25 AM
Daré Bioscience Reports First Quarter 2019 Financial Results and Company UpdateDaré Bioscience Reports First Quarter 2019 Financial Results and Company Update
finance.yahoo.com - May 14 at 7:13 PM
Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1, a Potential Therapy for Preterm Birth and Fertility, in Drug Delivery and Translational ResearchDaré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1, a Potential Therapy for Preterm Birth and Fertility, in Drug Delivery and Translational Research
finance.yahoo.com - May 8 at 9:19 AM
Daré Bioscience to Host First Quarter 2019 Financial Results and Company Update Conference Call and WebcastDaré Bioscience to Host First Quarter 2019 Financial Results and Company Update Conference Call and Webcast
finance.yahoo.com - May 7 at 9:18 AM
Dr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical DevelopmentDr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical Development
www.globenewswire.com - April 15 at 11:19 AM
Daré Bio down 23% on pricing stock offeringDaré Bio down 23% on pricing stock offering
seekingalpha.com - April 9 at 9:48 AM
Daré Bioscience, Inc. Prices Underwritten Public Offering of Common StockDaré Bioscience, Inc. Prices Underwritten Public Offering of Common Stock
finance.yahoo.com - April 9 at 9:48 AM
DARE: Pipeline Timelines Intact. Several Development-Related Milestones UpcomingDARE: Pipeline Timelines Intact. Several Development-Related Milestones Upcoming
finance.yahoo.com - April 9 at 9:48 AM
Daré Bioscience announces proposed public offering of common stockDaré Bioscience announces proposed public offering of common stock
seekingalpha.com - April 8 at 6:51 PM
Daré Bioscience, Inc. Announces Proposed Public Offering of Common StockDaré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 8 at 6:51 PM
Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical SciencesDaré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
finance.yahoo.com - April 8 at 11:06 AM
Edited Transcript of DARE earnings conference call or presentation 4-Apr-19 12:30pm GMTEdited Transcript of DARE earnings conference call or presentation 4-Apr-19 12:30pm GMT
finance.yahoo.com - April 4 at 11:47 PM
Daré Bioscience, Inc. Regains Listing Compliance on NasdaqDaré Bioscience, Inc. Regains Listing Compliance on Nasdaq
finance.yahoo.com - April 1 at 6:45 PM
Daré Bioscience, Inc. to Host Business Update and Full Year 2018 Financial Results Conference Call and WebcastDaré Bioscience, Inc. to Host Business Update and Full Year 2018 Financial Results Conference Call and Webcast
finance.yahoo.com - April 1 at 9:36 AM
World-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory BoardWorld-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory Board
finance.yahoo.com - March 29 at 9:32 AM
Thinking about buying stock in Altimmune Inc., Dare Bioscience Inc., Phasebio Pharmaceuticals Inc., Stoneco Ltd., or Tilray Inc.? - PRNewswireThinking about buying stock in Altimmune Inc., Dare Bioscience Inc., Phasebio Pharmaceuticals Inc., Stoneco Ltd., or Tilray Inc.? - PRNewswire
www.prnewswire.com - March 21 at 9:32 AM
U.S. STOCKS ON THE MOVE-Boeing, Facebook, Dare BioscienceU.S. STOCKS ON THE MOVE-Boeing, Facebook, Dare Bioscience
www.nasdaq.com - March 19 at 9:38 AM
Clinical Trials for Leukemia Exhibiting Encouraging AdvancementsClinical Trials for Leukemia Exhibiting Encouraging Advancements
www.marketwatch.com - March 19 at 9:38 AM
Dare Bioscience, Inc. Estimate MomentumDare Bioscience, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 6:47 PM
Dare Bioscience Skyrockets On Positive Data For Vaginal Dryness DrugDare Bioscience Skyrockets On Positive Data For Vaginal Dryness Drug
www.msn.com - March 18 at 6:47 PM
Daré Bio up 154% on positive tamoxifen dataDaré Bio up 154% on positive tamoxifen data
seekingalpha.com - March 18 at 6:47 PM
Dare Bioscience Inc.Dare Bioscience Inc.
www.barrons.com - March 18 at 6:47 PM
Dare Bioscience stock rockets to pace all gainers after positive findings from VVA treatment studyDare Bioscience stock rockets to pace all gainers after positive findings from VVA treatment study
www.marketwatch.com - March 18 at 6:47 PM
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel